Home PDCI

08

Sep2023

PDCI Strengthens Leadership to Enhance Real World Evidence (RWE) Services and Strategic Consulting Capabilities

Mississauga, ON - September 11, 2023 – Canada’s leading biopharmaceutical pricing and reimbursement consultancy, PDCI Market Access (PDCI), a division of McKesson Canada, today announced the appointment of three leaders, Nabil Tadros, Andrea Lau and John-Paul Dowson to further enhance the company’s capabilities in delivering high-quality services and ... Read More

02

May2023

PDCI’s Webinar Series: Tips for Health Technology Assessment (HTA) Submissions: Plan your Trip, Pack your Bags and Leave on Time

Join us on May 31st @ 12 p.m. ET for our upcoming webinar entitled: Tips for Health Technology Assessment (HTA) Submissions: Plan your Trip, Pack your Bags and Leave on Time. Join PDCI HTA Experts Andrea Lau (Associate Director, HTA and Clinical Evaluation), Tuhin Maity (Associate ... Read More

05

Dec2022

PDCI Well Wishes for Managing Director Kaitlyn Proulx

PDCI is congratulating its Managing Director, Kaitlyn Proulx, as she begins parental leave effective November 28, 2022.Since joining PDCI in 2010, Kaitlyn has demonstrated incredible strategic insights advising clients on optimizing pricing and market access in Canada. Since becoming Managing Director in 2017, Kaitlyn has ... Read More

22

Nov2022

Fireside Chat: Trends to Watch in 2023
PDCI’s Lunch Time Educational Webinar Series

SAVE THE DATE: Join us on November 29 @ 12 p.m. for our last webinar of the year closing on the Top 3 Trends to Watch in Market Access in 2023. PDCI’s Directors will host a Fireside Chat to share their expertise on the trends to watch in 2023; John ... Read More

22

Nov2022

PDCI Well Wishes for Managing Director Kaitlyn Proulx

PDCI is congratulating its Managing Director, Kaitlyn Proulx, as she begins parental leave effective November 28, 2022.Since joining PDCI in 2010, Kaitlyn has demonstrated incredible strategic insights advising clients on optimizing pricing and market access in Canada. Since becoming Managing Director in 2017, Kaitlyn has ... Read More

07

Dec2021

WHITEPAPER: Uncovering the Hidden Costs of Take-Home Cancer Drugs

In cancer care, patients often face increased anxiety and uncertainty about their future care pathway. This is paired with an immediate need for therapy to treat potentially aggressive disease. Coverage eligibility for THCD varies significantly across Canadian provinces, creating interprovincial differences. Gaps in coverage of THCDs across provinces lead to inequitable ... Read More

13

Sep2021

Welcome to the PDCI Team

PDCI Welcomes Véronique Scott & Ishan Kumar to the Team Ishan Kumar joins PDCI as Manager, Data Innovation and Insights. As a member of PDCI’s data insights team, Ishan’s role includes designing ... Read More

29

Jun2021

Welcome Jessica Birrell and Rachel Arcand to the PDCI Team!

PDCI Market Access has further expanded its Market Access Team! Jessica joins PDCI as Manager, Market Access.  She will be responsible for coordinating our pricing and market access projects including HTA and payer ... Read More

11

May2021

PDCI Market Access Releases New Issue of INSIGHTS Magazine Perspectives on Plan Sponsors and New Coverage Insights

PDCI releases the latest issue of PDCI Market Access INSIGHTS, featuring research and opinion on the evolving state of private health insurance in Canada.   IN THIS ISSUE: Commentary  Private Drug Plan Management in Canada—is it really a big deal? Noel MacKay and Tari Duguay share a provocative essay on ... Read More

24

Mar2021

REMINDER: PDCI Sharing Sites for Policy Submissions Open for Contribution!

This is a reminder that PDCI is inviting all stakeholders to share their input for public awareness and information. PDCI strives to support timely transparency around public policy consultations and invites organizations and individuals to share their submissions here so ideas ... Read More